Effect of a prolyl endopeptidase inhibitor, JTP-4819, on radial maze performance in hippocampal-lesioned rats

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 2, 1998, Pages 361-368

  Miyazaki, A ^a   Toide, K ^a   Sasaki, Y ^b   Ichitani, Y ^b   Iwasaki, T ^b  

^a JAPAN TOBACCO INC   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Choline acetyltransferase; Eight arm radial maze; Hippocampal lesion; JTP 4819; Muscarinic 1 receptor rat; Prolyl endopeptidase; Spatial memory

Indexed keywords

N BENZYL 2 [[2 (HYDROXYACETYL) 1 PYRROLIDINYL]CARBONYL] 1 PYRROLIDINECARBOXAMIDE; NEUROPEPTIDE; PROLYL ENDOPEPTIDASE; PROLYL ENDOPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; LEARNING; LEARNING DISORDER; MALE; MAZE TEST; NONHUMAN; ORAL DRUG ADMINISTRATION; PERFORMANCE; PRIORITY JOURNAL; RAT; SPATIAL MEMORY;

ANIMALS; BASAL GANGLIA; CEREBRAL CORTEX; CHOLINE O-ACETYLTRANSFERASE; HIPPOCAMPUS; MALE; MAZE LEARNING; PIRENZEPINE; PYRROLIDINES; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS;

EID: 0032004923     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00420-6     Document Type: Article

References (49)

1. Bartus R. T., Dean R. L. III, Beer B., Lippa A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
2. Beal M. F., Mazurck M. F. Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex. Neurology. 37:1987;1205-1209.
3. Brinton R. D., Monreal A. W., Fernandez J. G. Vasopressin-induced neurotrophism in cultured hippocampal neurons via V1 receptor activation. J. Neurobiol. 25:1994;380-394.
4. Casabona G., Bruno V., Catania M. V., Sortino M. A., Nicoletti F., Scapagnini U., Canonico L. Thyrotropin-releasing hormone (TRH) and its analog, RGH-2202, accelerate maturation of cerebellar neurons in vitro. Dev. Brain Res. 69:1992;179-183.
5. Coyle J. T., Donald L. P., Delong M. R. Alzheimer's disease. A disorder of cortical cholinergic innervation Science. 219:1983;1184-1190.
6. Decker M. W., Curzon P., Brioni J. D. Influence of separate and combined septal and amygdala lesions on memory, acoustic startle, anxiety, and locomotor activity in rats. Neurobiol. Learn. Mem. 64:1995;156-168.
7. De Wied D., Gaffori O., Ree J. M., Jong W. Central target for the behavioral effects of vasopressin neuropeptides. Nature. 308:1984;276-280.
8. Ferrier I. N., Cross A. J., Johnson J. A., Robrets G. W., Crow T. J., Corsellis J. A. N., Lee Y. C., O'shaughnessy D., Adrian T. E., Mcgregor G. P., Baracesehamilton A. J., Bloom S. R. Neuropeptides in Alzheimer type dementia. J. Neurol. Sci. 62:1983;159-170.
9. Gallagher M., Colombo P. J. Ageing. The cholinergic hypothesis of cognitive decline Cur. Opin. Neurobiol. 5:1995;161-168.
10. Giovannini M. G., Casamenti F., Nistri A., Paoli F., Pepeu G. Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis. Br. J. Pharmacol. 102:1991;363-368.
11. 3H] dopa in various regions of the brain J. Neurochem. 13:1966;655-669.
12. Hasenohrl R. U., Huston J. P., Schuurman T. Neuropeptide substance P improves water maze performance in aged rats. Psychopharmacology. 101:1990;23-26.
13. Hiraga Y., Iwasaki T. Effects of cholinergic and monoaminergic antagonists and tranquilizers upon spatial memory in rats. Pharmacol. Biochem. Behav. 20:1984;205-207.
14. Husain M. M., Nemeroff C. B. Neuropeptides and Alzheimer's disease. J. Am. Geriatr. Soc. 38:1990;918-925.
15. Huston J. P., Hasenohrl R. U., Gerhardt P., Schwarting R. K. W. Sequences-specific effects of neurokinin substance P on memory, reinforcement and brain dopamine activity. Psychopharmacology. 112:1991;146-162.
16. Iwasaki J., Kinoshita M., Ikeda K., Takamiya K., Shiojima T. Trophic effect of various neuropeptides on the cultured ventral spinal cord of rat embryo. Neurosci. Lett. 101:1989;316-320.
17. Iwasaki Y., Ikeda K., Shiojima T., Kinoshita M. TRH analogue, TA-0910 (3-methyl-(s) 5,6-dihydroorotyl-l-histidyl-l-prolinamide) enhances neurite outgrowth in rat embryo ventral spinal cord in vitro. J. Neurol. Sci. 112:1992;147-151.
18. Kalwant S., Porter A. G. purification and characterization of human brain prolyl endopeptidase. Biochem. J. 276:1991;237-244.
19. Kaneda N., Nagatsu T. Highly sensitive assay for choline acetyltransferase activity by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 341:1985;23-30.
20. Knisatschek H., Bauer K. Specific inhibition of post proline cleaving enzyme by benzyloxycarbonyl-Gly-Pro-Diazomethyl ketone. Biochem. Biophys. Res. Commun. 134:1986;888-894.
21. Koida M., Walter R. Post-proline cleaving enzyme. J. Biol. Chem. 251:1976;7593-7599.
22. Kozlova M. V., Ilyinski 0. B., Kalentchuk V. A., Kondrikova E. S. Stimulatory effect of substance P on sympathetic ganglia and spinal cord in culture. Neurosci. Lett. 82:1987;16-20.
23. Lippa A. S., Pelham R. W., Beer B., Critchett D. J., Dean R. L., Bartus R. T. Brain cholinergic dysfunction and memory in aged rats. Neurobiol. Aging. 1:1980;13-19.
24. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with Folin phenol reagent, J. Biol. Chem. 193:1951;265-275.
25. Mesulam M. M., Mufson E. J., Wainer B. H., Levey A. I. Central cholinergic pathways in the rat. An overview based on an alternative nomenclature (Ch1-Ch6) Neuroscience. 10:1983;1185-1201.
26. Metzger D., Alescio-Ladier B., Bosler O., Devigne C., Soumireu-Mourat B. Effect of changes in the intrahippocampal vasopressin on memory retrieval and relearning. Behav. Neural. Biol. 59:1993;29-48.
27. Morris R. G. M., Garrud P., Rawlins J. N. P., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature. 297:1982;681-683.
28. Olton D. S., Samuelson R. J. Remembrance of places passed:Spatial memory in rats. J. Exp. Psychol. (Anim. Behav. Proc.). 2:1976;97-116.
29. Olton D. S., Papas B. C. Spatial memory and hippocampal function. Neuropsychologia. 17:1979;669-682.
30. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2:1986;Academic Press, San Diego.
31. Perry E. K. The cholinergic hypothesis. Ten years on. Br. Med. Bull. 42:1986;63-69.
32. Rossor M. N., Emson P. C., Dawbarn D., Mountjoy C. Q., Roth M. Neuropeptide and dementia. Prog. Brain. Res. 66:1986;143-159.
33. Schlesinger K., Lipsitz D. U., Peck P. L., Pelleymounter M. A., Stewart J. M., Chase T. N. Substance P enhancement of passive and active avoidance conditioning in mice. Pharmacol. Biochem. Behav. 19:1983;655-661.
34. Schmidt-Achert K. M., Askanas V., Engel W. K. Thyrotropin-releasing hormone enhances choline acetyltransferase and creatine kinase in cultured spinal ventral horn neurons, J. Neurochem. 43:1984;586-589.
35. Shinoda M., Okamiya K., Toide K. Effect of a novel endopeptidase inhibitor, JTP-4819, on thyrotropin-releasing hormone-like immunoreactivity in the cerebral cortex and hippocampus of aged rats. Jpn. J. Pharmacol. 69:1995;273-276.
36. Shinoda M., Matsuo A., Toide K. Pharmacological studies of a novel endopeptidase inhibitor, JTP-4819, in rats with middle cerebral artery occlusion. Eur. J. Pharmacol. 305:1996;31-38.
37. Taira K., Kaneto H. Experimental models for studying the avoidance response in mice and the anti-amnesic effect of prolyl endopeptidase inhibitors. Folia Pharmacol. Jn. 89:1987;243-252.
38. Taylor W. L., Dixon J. E. Catabolism of neuropeptides by a brain proline endapeptidase, Biochem. Biophys. Res. Commun. 94:1980;9-15.
39. Toide K., Fujiwara T., Iwamoto Y., Shinoda M., Okamiya K., Kato T. Effect of a novel prolyl endopeptidase (PEP) inhibitor, JTP-4819, on neuropeptides metabolism in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 353:1996;355-362.
40. Toide K., Iwamoto Y., Fujiwara T., Abe H. JTP-4819. A novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer J. Pharmacol. Exp. Ther. 274:1995;1370-1378.
41. Toide, K,; Iwamoto, Y.; Fujiwara, T.; Okamiya, K.: A novel prolyl endopeptidase (PEP) inhibitor, JTP-4819, activates peptidergic-cholinergic neurotransmission as a cognitive enhancer: Implications and mechanism of action. In:Louilot, A.; Durkin, T.; Spampinate, U.; Cador, M., eds. Proceedings of the 6th international conference in neuroscience: Monitoring molecules in neuroscience. Acheve d'imprimer sur les Presses; 1994:273-274.
42. Toide K., Okamiya K., Iwamoto Y., Kato T. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819 on prolyl endopeptidase activity and substance P- and arginine-vasopressin-like immunoreactivity in the brains of aged rats. J. Neurochem. 65:1995;234-240.
43. Toide K., Shinoda M., Fujiwara T., Iwamoto Y. Effect of a novel prolyl endopeptidase inhibitor, on spatial memory and central cholinergic neurons in aged rats. Pharmacol. Biochem, Behav. 56:1997;427-434.
44. Toide K., Shinoda M., Takase M., Iwata K., Yoshida H. Effects of a novel thyrotropin-releasing hormone analogue, JTP-2942, on extracellular acetylcholine and choline levels in the rat frontal cortex and hippocampus. Eur. J. Pharmacol. 233:1993;21-28.
45. Walter R., Shlank H., Glass J. D., Schwartz I. L., Kerenyi T. D. Leucylglycinamide released from oxytocin by human enzyme. Science. 173:1971;827-829.
46. Walter R., Simmons W. H., Yoshimoto T. Proline specific endo- and exopeptidases. Mol. Cell. Biochem. 30:1980;111-127.
47. Whitehouse P. J., Price D. L., Struble R. G., Clark A. W., coyle J. T., Delong M. R. Alzheimer's disease. and senile dementia: Loss of neurons in the basal forebrain Science. 215:1982;1237-1239.
48. Yoshimoto T., Nishimura T., Kita T., Tsuru D. Post-proline cleaving enzyme (Prolyl endopeptidase) from bovine brain. J. Biochem. 94:1983;1179-1190.
49. Yoshimoto T., Ogita K., Walter R., Koida M., Tsuru D. Synthesis of a new fluorogenic substrate and distribution of the endopeptidase in rat tissues and body fluids of man. Biochem. Biophys. Acta. 569:1979;184-192.